β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof
申请人:Quadriga Biosciences, Inc.
公开号:US10017459B2
公开(公告)日:2018-07-10
β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and methods of using the compounds for treating cancer are also disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs exhibit selective uptake in tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres exhibit cytotoxicity toward several tumor types.
本研究公开了 β-取代的 β-氨基酸、β-取代的 β-氨基酸衍生物和 β-取代的 β-氨基酸类似物和(生物)异构体及其作为化疗药物的用途。β-取代的β-氨基酸衍生物和β-取代的β-氨基酸类似物和(生物)异甾烷是选择性的 LAT1/4F2hc 底物,在表达 LAT1/4F2hc 转运体的肿瘤中表现出快速吸收和滞留。此外,还公开了β-取代的β-氨基酸衍生物和β-取代的β-氨基酸类似物的合成方法以及使用这些化合物治疗癌症的方法。β-取代的β-氨基酸衍生物和β-取代的β-氨基酸类似物在表达LAT1/4F2hc转运体的肿瘤细胞中表现出选择性吸收,并且在体内给受试者用药时会在癌细胞中蓄积。β-取代的 β-氨基酸衍生物和 β-取代的 β-氨基酸类似物及(生物)异构体对多种肿瘤类型具有细胞毒性。